MILLIGAN JOHN F
SEC insider (Form 3/4/5 filer). CIK 0001191589. Director at 4D Molecular Therapeutics, Inc. (FDMT) and 2 other issuers. 5 reported Form 4/5 transactions since Sep 2024; latest on Jun 17, 2026. Located in MENLO PARK, CA.
Companies MILLIGAN JOHN F has filed insider reports for
- 4D Molecular Therapeutics, Inc. (FDMT): Director
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB): Director
- Kailera Therapeutics, Inc. (KLRA): Director
MILLIGAN JOHN F
CIK: 0001191589
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jun 17, 2026FDMT
4D Molecular Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
75K shares- - Jun 3, 2026PACB
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
AwardDirectStock Option (right to buy)
223.5K shares- - Apr 16, 2026KLRA
Kailera Therapeutics, Inc.
AwardDirectStock Option (right to buy)
38.3K shares- - Jun 17, 2025FDMT
4D Molecular Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
33.8K shares- - Jun 4, 2025PACB
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
AwardDirectStock Option (right to buy)
65K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 17, 2026 |  FDMT 4D Molecular Therapeutics, Inc. | Award Stock Option (Right to Buy) | 75,000 | - | - | Direct |
| Jun 3, 2026 |  PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Award Stock Option (right to buy) | 223,492 | - | - | Direct |
| Apr 16, 2026 |  KLRA Kailera Therapeutics, Inc. | Award Stock Option (right to buy) | 38,300 | - | - | Direct |
| Jun 17, 2025 | FDMT 4D Molecular Therapeutics, Inc. | Award Stock Option (Right to Buy) | 33,750 | - | - | Direct |
| Jun 4, 2025 | PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Award Stock Option (right to buy) | 65,000 | - | - | Direct |
1-5 of 5 transactions